Skip to main content

Table 1 Clinical characteristics of the studied population

From: Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study

Variables

Non-CAD (n = 88)

CAD (n = 88)

P

Age (year)

58.25 ± 8.46

59.19 ± 7.9

0.446

Sex [male]

63 (71.6%)

58 (65.9%)

0.258

BMI (kg/m2)

25.23 ± 3.52

25.65 ± 3.86

0.457

SBP (mmHg)

127.25 ± 16.38

130.61 ± 18.97

0.210

DBP (mmHg)

80.43 ± 11.22

83.22 ± 13.19

0.133

FBG (mg/dL)

93.49 ± 12.2

95.38 ± 11.98

0.303

Insulin (uU/mL)

4.07 ± 2.9

6.11 ± 4.03

< 0.001

HOMA-IR

0.96 ± 0.69

1.48 ± 1.018

< 0.001

TG (mg/dL)

115.9 ± 46.83

143.94 ± 55.06

< 0.001

TC (mg/dL)

165.52 ± 36.46

176.27 ± 46.39

0.089

LDL-C (mg/dL)

99.89 ± 29.74

106.85 ± 31.32

0.132

HDL-C (mg/dL)

44.28 ± 7.64

41.26 ± 9.49

0.021

Cr (mg/dL)

1.13 ± 0.17

1.13 ± 0.17

0.944

AST (U/L)

16.24 ± 4.62

18.5 ± 5.79

0.005

ALT (U/L)

16.5 ± 6.69

19 ± 7.27

0.019